Positive PsychoTherapy in Acquired Brain Injury (ABI) Rehabilitation (PoPsTAR)

January 7, 2015 updated by: NHS Greater Glasgow and Clyde

Brief Positive Psychotherapy After Acquired Brain Injury: A Pilot Randomised Controlled Trial

Stroke, head injury and other forms of brain injury are a major cause of physical, psychological and social disability in the adult population. Psychological distress is common following brain injury, but the evidence base for specific psychotherapeutic methods in this population is limited, and standard treatment approaches may not be suitable. Recently there has been a growing interest in positive psychology - the study of wellbeing, positive emotions and characteristics, and personal growth. The investigators believe that positive psychotherapy interventions may be beneficial after acquired brain injury, to reduce psychological morbidity. Because such interventions have not previously been applied in this population, the investigators propose to conduct a pilot randomised controlled trial to examine the feasibility of a brief positive psychotherapy intervention in an out-patient setting. This project will produce essential information to allow us to plan future full-scale clinical trials in this area.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

37

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Glasgow, United Kingdom
        • NHS Greater Glasgow and Clyde

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Aged 18 years or over;
  • Diagnosis of stroke or acquired brain injury (confirmed clinically and/or radiologically);
  • Between 3 and 12 months post-injury at time of recruitment;
  • Presence of emotional distress (score in moderate or above range on at least one sub-scale of the Depression Anxiety Stress Scales; DASS-21);
  • Medically stable;
  • Able to consent to research.

Exclusion Criteria:

  • Significant communication impairments that would preclude participation;
  • Diagnosis of mild traumatic brain injury (due to the known additional complexities contributing to outcome in this population);
  • Comorbid developmental learning disability or degenerative neurological condition.

Pre-injury history of mood disorder will not lead to exclusion.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Treatment as usual
Standard NHS care for the patient group (NHS care will vary as participants will be recruited from a variety of NHS clinics).
Experimental: Psychotherapy
Brief psychotherapy intervention delivered over 8 weeks in addition to standard care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Recruitment rate at 20 weeks from baseline
Time Frame: 20 weeks
20 weeks
Treatment adherence at 20 weeks from baseline
Time Frame: 20 weeks
20 weeks
Sample retention at 20 weeks from baseline
Time Frame: 20 weeks
20 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Correlation coefficient between first and second baseline administrations of the Authentic Happiness Inventory (AHI) and VIA-IS questionnaires
Time Frame: 1 week
1 week
Change in Depression Anxiety Stress Scales (DASS-21) scores at 20 weeks from baseline
Time Frame: 20 weeks
20 weeks
Changes in AHI scores at 20 weeks from baseline
Time Frame: 20 weeks
20 weeks
Likert ratings of participants and therapists experiences of treatment delivery
Time Frame: 8 weeks
8 weeks
Changes in Mayo-Portland Adaptability Inventory (MPAI-4) scores at 20 weeks at baseline
Time Frame: 20 weeks
20 weeks
Changes in Modified Caregiver Strain Index (MCSI) scores at 20 weeks from baseline
Time Frame: 20 weeks
20 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Jonathan Evans, PhD, University of Glasgow

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2013

Primary Completion (Actual)

May 1, 2014

Study Completion (Actual)

October 1, 2014

Study Registration Dates

First Submitted

May 20, 2013

First Submitted That Met QC Criteria

June 3, 2013

First Posted (Estimate)

June 4, 2013

Study Record Updates

Last Update Posted (Estimate)

January 8, 2015

Last Update Submitted That Met QC Criteria

January 7, 2015

Last Verified

January 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • GN12CP391
  • CZH/4/778 (Other Grant/Funding Number: Chief Scientist Office)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acquired Brain Injury

Clinical Trials on Psychotherapy

Subscribe